1. Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020; 11(3):79-87. [DOI:10.14740/wjon1279] [PMID] []

2. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis primers. 2017; 3:17009. [DOI:10.1038/nrdp.2017.9] [PMID] []

3. Feng C, Lyu Y, Gong L, Wang J. Therapeutic potential of natural products in the treatment of renal cell carcinoma: a review. Nutrients. 2022; 14(11):2274. [DOI:10.3390/nu14112274] [PMID] []

4. Sen NP, Smith DC, Schwinghamer L, Marleau JJ. Diethylnitrosamine and other N-nitrosamines in foods. J AOAC Int. 1969; 52(1):47-52. [DOI:10.1093/jaoac/52.1.47]

5. Beigmohammadi F. Evaluation of the effect of boiling and deep frying as cooking method on the amounts of volatile nitrosamines and polycyclic aromatic hydrocarbons (PAHs) of smoked cocktailsof volatile nitrosamines and polycyclic aromatic hydrocarbons (PAHs) of smoked cocktails. J Food Sci Technol. 2022; 18(121): 117-29. (Full text in Persian) [DOI:10.52547/fsct.18.121.10]

6. Tolba R, Kraus T, Liedtke C, Schwarz M, Weiskirchen R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015; 49(1_suppl):59-69. [DOI:10.1177/0023677215570086] [PMID]

7. Schulien I, Hasselblatt P. Diethylnitrosamine-induced liver tumorigenesis in mice. Methods Cell Biol. 2021; 163:137-52. [DOI:10.1016/bs.mcb.2020.08.006] [PMID]

8. Connor F, Rayner TF, Aitken SJ, Feig C, Lukk M, Santoyo-Lopez J, et al. Mutational landscape of a chemically-induced mouse model of liver cancer. J Hepatol. 2018; 69(4):840-50. [DOI:10.1016/j.jhep.2018.06.009] [PMID] []

9. Mohr U, Hilfrich J. Effect of a single dose of N-diethylnitrosamine on the rat kidney. J Natl Cancer Inst. 1972; 49(6):1729-31. [DOI:10.1093/jnci/49.6.1729] [PMID]

10. Hassanen NH, Fahmi A, Shams-Eldin E, Abdur-Rahman M. Protective effect of rosemary (Rosmarinus officinalis) against diethylnitrosamine-induced renal injury in rats. Biomarkers. 2020; 25(3):281-9. [DOI:10.1080/1354750X.2020.1737734] [PMID]

11. Mehany AB, Farrag IM, Diab M, Ghoneim MM, El-Sherbiny M, Al-Serwi RH, et al. Curcumin and vitamin C improve immunity of kidney via gene expression against diethyl nitrosamine induced nephrotoxicity in rats: In vivo and molecular docking studies. Heliyon. 2023; 9(3):e14126. [DOI:10.1016/j.heliyon.2023.e14126] [PMID] []

12. Oz M, El Nebrisi EG, Yang KH, Howarth FC, Al Kury LT. Cellular and molecular targets of menthol actions. Front Pharmacol. 2017; 8:472. [DOI:10.3389/fphar.2017.00472] [PMID] []

13. Kamatou GP, Vermaak I, Viljoen AM, Lawrence BM. Menthol: A simple monoterpene with remarkable biological properties. Phytochem. 2013; 96:15-25. [DOI:10.1016/j.phytochem.2013.08.005] [PMID]

14. Liu Z, Shen C, Tao Y, Wang S, Wei Z, Cao Y, et al. Chemopreventive efficacy of menthol on carcinogen-induced cutaneous carcinoma through inhibition of inflammation and oxidative stress in mice. Food Chem Toxicol. 2015; 82:12-18. [DOI:10.1016/j.fct.2015.04.025] [PMID]

15. Wang Y, Wang X, Yang Z, Zhu G, Chen D, Meng Z. Menthol inhibits the proliferation and motility of prostate cancer DU145 cells. Pathol Oncol Res. 2012; 18:903-10. [DOI:10.1007/s12253-012-9520-1] [PMID]

16. Li Q, Wang X, Yang Z, Wang B, Li S. Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24. Oncology. 2010; 77(6):335-41. [DOI:10.1159/000264627] [PMID]

17. Santo SG, Romualdo GR, Santos LA, Grassi TF, Barbisan LF. Modifying effects of menthol against benzo (a) pyrene‐induced forestomach carcinogenesis in female Swiss mice. Environ Toxicol. 2021; 36(11):2245-55. [DOI:10.1002/tox.23338] [PMID]

18. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001; 25(4):402-408. [DOI:10.1006/meth.2001.1262] [PMID]

19. Awakura Y, Nakamura E, Ito N, Kamoto T, Ogawa O. Methylation-associated silencing of SFRP1 in renal cell carcinoma. Oncol Rep. 2008; 20(5):1257-63.

20. Mo S, Su Z, Heng B, Chen W, Shi L, Du X, et al. SFRP1 promoter methylation and renal carcinoma risk: A systematic review and meta-analysis. J Nippon Med Sch. 2018; 85(2):78-86. [DOI:10.1272/jnms.2018_85-13] [PMID]

21. Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, et al. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. J Cancer Res Clin Oncol. 2020; 146:1153-67. [DOI:10.1007/s00432-020-03182-1] [PMID] []

22. Yang CM, Ji S, Li Y, Fu LY, Jiang T, Meng FD. β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. Onco Targets Ther. 2017;10:711-24. [DOI:10.2147/OTT.S117933] [PMID] []

23. Moselhy J, Srinivasan S, Ankem MK, Damodaran C. Natural products that target cancer stem cells. Anticancer Res. 2015; 35(11):5773-88.

24. Kaelin Jr WG. The von Hippel-Lindau tumor suppressor gene and kidney cancer. Clin Cancer Res. 2004; 10: 6290S-6295S. [DOI:10.1158/1078-0432.CCR-sup-040025] [PMID]

25. Temm CJ, Shively SB, Vortmeyer AO. Kidney in VHL disease: Early clear cell proliferation occurs in the distal tubular system. Oncol Rep. 2022; 48(6):1-8. [DOI:10.3892/or.2022.8437] [PMID] []

26. Baldewijns MM, van Vlodrop IJ, Vermeulen PB, Soetekouw PM, van Engeland M, de Bruïne AP. VHL and HIF signalling in renal cell carcinogenesis. J Pathol. 2010; 221(2):125-38. [DOI:10.1002/path.2689] [PMID]

27. Mazumder S, Higgins PJ, Samarakoon R. Downstream targets of VHL/HIF-α signaling in renal clear cell carcinoma progression: mechanisms and therapeutic relevance. Cancer. 2023; 15(4):1316. [DOI:10.3390/cancers15041316] [PMID] []

28. Wan L, Huang J, Chen J, Wang R, Dong C, Lu S, et al. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma. J BUON. 2015; 20(1):188-95.

29. Manolescu B, Oprea E, Busu C, Cercasov C. Natural compounds and the hypoxia-inducible factor (HIF) signalling pathway. Biochim. 2009; 91(11-12):1347-58. [DOI:10.1016/j.biochi.2009.08.005] [PMID]

30. Tao XK, Zhang XT, Wang HC, Duan H, Cheng J. Effect of menthol on proliferation, migration and expressions of IL-8, CXCL-12 and VEGF in hepatoma HepG2 cells. Chinese J Experiment Trad Med Formul. 2019;24:60-5. [Full text in Chinese]

31. Huang Y, Li S, Jia Z, Zhao W, Zhou C, Zhang R, et al. Transient receptor potential melastatin 8 (TRPM8) channel regulates proliferation and migration of breast cancer cells by activating the AMPK-ULK1 pathway to enhance basal autophagy. Front Oncol. 2020; 10:573127. [DOI:10.3389/fonc.2020.573127] [PMID] []

32. Nazıroğlu M, Blum W, Jósvay K, Çiğ B, Henzi T, Oláh Z, et al. Menthol evokes Ca2+ signals and induces oxidative stress independently of the presence of TRPM8 (menthol) receptor in cancer cells. Redox Biol. 2018; 14:439-49. [DOI:10.1016/j.redox.2017.10.009] [PMID] []

33. Zhao Y, Pan H, Liu W, Liu E, Pang Y, Gao H, et al. Menthol: An underestimated anticancer agent. Front Pharmacol. 2023; 14:1148790. [DOI:10.3389/fphar.2023.1148790] [PMID] []